Home » BD Announces FDA 510(k) Clearance of Molecular Assay
BD Announces FDA 510(k) Clearance of Molecular Assay
BD Diagnostics, a segment of BD announced it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm Cdiff molecular assay for the rapid detection of the Toxin B gene found in toxigenic Clostridium difficile, the bacterial pathogen responsible for Clostridium difficile infection (CDI).
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May